Rheumatoid arthritis: current therapeutics compendium Cover

.blurhash-client-img { display: none !important; }

Rheumatoid arthritis: current therapeutics compendium

Endocrine Regulations

Volume 56 (2022): Issue 2 (April 2022)

By: Hassan Dariushnejad, Leila Chodari, Mehrnoosh Sedighi, Soheila Akbari and Vajihe Ghorbanzadeh

Open Access

|Apr 2022

Authors

Hassan Dariushnejad

Department of Medical Biotechnology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad

Leila Chodari

Department of Medical Physiology, Urmia University of Medical Sciences, Urmia

Mehrnoosh Sedighi

Cardiovascular Research Center, Shahid Rahimi Hospital, Lorestan University of Medical Sciences, Khorramabad

Soheila Akbari

Department of Obstetrics and Gynecology, Lorestan University of Medical Sciences, Khorramabad

Vajihe Ghorbanzadeh

vghorbanzadeh@gmail.com

Cardiovascular Research Center, Shahid Rahimi Hospital, Lorestan University of Medical Sciences, Khorramabad

DOI: https://doi.org/10.2478/enr-2022-0016 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668

Journal RSS Feed

Language: English

Page range: 148 - 162

Published on: Apr 30, 2022

Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

rheumatoid arthritis,

biological therapeutics,

monoclonal antibody

Related subjects:

Molecular biology,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Internal medicine,

Endocrinology, diabetology

© 2022 Hassan Dariushnejad, Leila Chodari, Mehrnoosh Sedighi, Soheila Akbari, Vajihe Ghorbanzadeh, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 56 (2022): Issue 2 (April 2022)